Pay in 4 interest-free payments of $5.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This peptide is not intended to diagnose, treat, cure, or prevent any disease
retatrutide is a GIP/GLP-1/glucagon triple agonist (appetite plus energy expenditure)
Scientific investigations commonly examine DSIP for its relationship with neuropeptide signaling, circadian regulation, hypothalamic pathways, intracellular communication, and peptide-mediated molecular mechanisms
GHRH (Growth Hormone-Releasing Hormone) analogs (e.g., tesamorelin): Used to treat lipodystrophy in HIV patients
Common (mild, transient): Injection site reactions mild erythema, swelling, itching, or discomfort, reported in ~15-25% of users
FDAs briefing said the criteria weighed against inclusion because of inconsistent substance naming, limited evidence, safety uncertainty and the availability of established treatments for the proposed conditions
US$ 20.47
US$ 20.55
US$ 21.18
US$ 23.98
US$ 21.82
US$ 23.61
US$ 25.37
US$ 20.24
US$ 25.11
US$ 22.75
